Could NC biotech Icagen get acquired by Pfizer?
Pfizer (NYSE:PFE) is taking a hard look at acquiring the NC biotech company Icagen (NASDAQ:ICGN) in a move that could bring a slate of pain drug candidates into the pipeline of the world’s largest pharmaceutical company. Pfizer has disclosed in a regulatory filing that it has started talks with the Durham-based company. Icagen, which is […]